Manufacturers Life Insurance Company, The Apellis Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 61,221 shares of APLS stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,221
Previous 73,135
16.29%
Holding current value
$2 Million
Previous $2.81 Million
37.08%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$509 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$389 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$363 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$321 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$189 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.59B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...